These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38732267)

  • 1. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.
    Loukas AT; Papadourakis M; Panagiotopoulos V; Zarmpala A; Chontzopoulou E; Christodoulou S; Katsila T; Zoumpoulakis P; Matsoukas MT
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Co-Culture System of Human Osteoblasts and Osteoclast Precursors from Osteoporotic Patients as an Innovative Model to Study the Role of Nutrients: Focus on Vitamin K2.
    Mandatori D; Penolazzi L; Pelusi L; Lambertini E; Michelucci F; Porreca A; Cerritelli P; Pipino C; Di Iorio A; Bruni D; Di Nicola M; Buda R; Piva R; Pandolfi A
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy Metabolism of Bone.
    Motyl KJ; Guntur AR; Carvalho AL; Rosen CJ
    Toxicol Pathol; 2017 Oct; 45(7):887-893. PubMed ID: 29096593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis.
    Zhao X; Patil S; Xu F; Lin X; Qian A
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis: now and the future.
    Rachner TD; Khosla S; Hofbauer LC
    Lancet; 2011 Apr; 377(9773):1276-87. PubMed ID: 21450337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.
    Kaur M; Nagpal M; Singh M
    Curr Drug Targets; 2020; 21(16):1640-1651. PubMed ID: 32735518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Development of Molecular Biology of Osteoporosis.
    Gao Y; Patil S; Jia J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.
    Xu Q; Zhan P; Li X; Mo F; Xu H; Liu Y; Lai Q; Zhang B; Dai M; Liu X
    J Cell Mol Med; 2021 Nov; 25(21):10126-10139. PubMed ID: 34651433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?
    Tonk CH; Shoushrah SH; Babczyk P; El Khaldi-Hansen B; Schulze M; Herten M; Tobiasch E
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological agents and natural compounds: available treatments for osteoporosis.
    Martiniakova M; Babikova M; Omelka R
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium-sensing receptor in bone metabolism: from bench to bedside and back.
    Cianferotti L; Gomes AR; Fabbri S; Tanini A; Brandi ML
    Osteoporos Int; 2015 Aug; 26(8):2055-71. PubMed ID: 26100412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis.
    Wu W; Xiao Z; Chen Y; Deng Y; Zeng D; Liu Y; Huang F; Wang J; Liu Y; Bellanti JA; Rong L; Zheng SG
    Mol Ther; 2020 Jun; 28(6):1518-1532. PubMed ID: 32304668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment.
    Kołodziejska B; Stępień N; Kolmas J
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts.
    Ryan JW; Reinke D; Kogawa M; Turner AG; Atkins GJ; Anderson PH; Morris HA
    Curr Drug Targets; 2013 Dec; 14(14):1683-8. PubMed ID: 24010964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium ranelate in osteoporosis.
    Reginster JY
    Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.
    Iolascon G; Resmini G; Tarantino U
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S19-22. PubMed ID: 24046050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future developments in osteoporosis therapy.
    Ng KW
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):371-84. PubMed ID: 19857200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
    Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.